Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T73671
(Former ID: TTDI01664)
|
|||||
Target Name |
Interferon (IFN)
|
|||||
Synonyms |
Interferon protein
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Hepatitis virus infection [ICD-11: 1E50-1E51] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Interferon | Drug Info | Phase 2 | Hepatitis C virus infection | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Interferon | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year. Influenza Other Respir Viruses. 2013 Sep;7(5):854-62. | |||||
REF 2 | Clinical pipeline report, company report or official report of Amarillo biosciences. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.